Crossmark

Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13054-019-2399-4

Published Online: 2019-04-03

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Poli, Elettra C

Alberio, Lorenzo

Bauer-Doerries, Anna

Marcucci, Carlo

Roumy, Aurélien

Kirsch, Matthias

De Stefano, Eleonora

Liaudet, Lucas

Schneider, Antoine G https://orcid.org/0000-0003-0576-7094
Funding

Funding for this research was provided by:

Fondation Leenaards
License Information

Text and Data Mining valid from 2019-04-03
More Information

Article History

Received: 18 January 2019

Accepted: 18 March 2019

First Online: 3 April 2019

Ethics approval and consent to participate

: The study protocol was approved by the Ethics Committee Vaud (2015-00010) and registered at(NCT02775123). Signed informed consent for study participation was obtained from all patients before enrolment into the trial.

: All patients enrolled in this trial consented for anonymous utilisation of the data in the form of a scientific publication.

: AS has received a grant from the Leenaards foundation. He has received speaker honoraria from Cytosorbent SA. All other authors stated that they have no conflict of interest to declare.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.